Italy General Surgical Devices Market

Italy General Surgical Devices Market Analysis

The Italy General Surgical Devices Market is expected to register a CAGR of 6.2% during the forecast period.

The pandemic had an adverse impact on the studied market. Various research studies shed light on the country's response to the pandemic. For instance, an article published in May 2022 in Frontiers stated that elective pediatric surgeries were canceled two days after the first positive patient was discovered. As all of the smaller local hospitals closed to centralize the treatment of critical diseases and trauma, attempting to limit the spread of the virus, the Rizzoli Orthopaedic Institute hospital was reorganized to receive the majority of fractures from the entire city. As a result, only trauma surgery and oncologic and urgent cases were permitted. However, initiatives by key market players such as product launches are expected to increase market growth. For instance, in September 2021, Canon Medical launched its latest 1.5T MR, the Vantage Elan/NX Edition. The new system completes Canon Medical's intelligent and productive MR portfolio. Thus, such initiatives are expected to increase market growth during the forecast period.

Factors such as rising demand for minimally invasive surgeries coupled with increasing cardiovascular diseases are expected to increase the market growth. According to an article published by the Minerva Cardiology and Angiology Journal, in June 2021, stated that it has been observed that the age-standardized estimates of cardiovascular disease prevalence in Italy are similar, but the country's crude prevalence is almost two times higher than the global prevalence (12.9% vs. 6.6%). Thus, the increasing prevalence of heart diseases is expected to fuel market growth in the country, as surgeries are often required.

Similarly, initiatives by key market players are another factor in market growth. For instance, in October 2021, Esaote proposed an open MRI system, Magnifico Open, with cutting-edge technology to satisfy clinical needs and address operational and financial demands. Magnifico Open is equipped with the most recent Esaote technologies, like Speed Up, to assure optimal image quality with reduced examination times. Thus, the abovementioned factors such as increasing cardiovascular diseases coupled with initiatives by key market players are expected to increase market growth.

However, stringent regulatory frameworks are expected to hinder the market growth.

Italy General Surgical Devices Market Trends

Cardiology Segment is Expected to Hold a Significant Market Share Over the Forecast Period

Factors such as increasing cardiovascular diseases coupled with increasing research studies are expected to increase the market growth over the forecast period. Various research studies provide insight into the increasing number of CVDs in the country. For instance, an article published in March 2021 in the National Library of Medicine, stated that Italy has an almost two-fold greater CVD prevalence than the rest of the world (12.9% vs. 6.6%), while age-standardized figures are nearly similar (6.2% vs. 6.3%). Hence, the country's demand for emergency procedures and surgeries is expected to increase. Thus, it is anticipated to generate demand for the surgical devices required in health centers, ultimately driving market growth during the forecast period. Furthermore, an article published in Europe PMC in March 2021 stated that Italy has an almost two-fold greater CVD prevalence than the rest of the world (12.9 percent vs. 6.6 percent), while age-standardized figures are similar (6.2% vs. 6.3%). Thus, as a large proportion of the population in the country is older and is likely to suffer from cardiac diseases, the demand for surgical devices used for the treatment is expected to increase over the forecast period. According to a research study that was published in December 2021 in the National Library of Medicine, an increasing number of cancer patients are dying from cardiovascular disease (CVD), particularly those who have survived longer than five years after receiving a diagnosis of breast, colorectal, prostate, bladder, or melanoma. According to our study, the most dangerous time for an increased risk of dying from CVD is during the acute phase of treatment and the first two years of follow-up. After that, the risk falls below that of the general population, possibly as a result of competitive cancer mortality and multidisciplinary surveillance. Hence, surgical treatment of CVD patients is important to prevent mortality in the country. Thus, such research studies provide insight into the urgent need for surgical treatment, which is expected to increase the market's growth.

Thus, the abovementioned factors, such as increased cardiovascular disease coupled with research studies, are expected to increase market growth over the forecast period.

Orthopaedic Segment is Expected to Hold a Significant Market Share Over the Forecast Period

The orthopedic segment is expected to increase over the forecast period due to increasing road injuries coupled with product launches in the country. Increasing road accidents in the country are one of the key factors in the growth of the market, as often the injured person requires some form of surgical treatment. For instance, in July 2022, a press release by ISTAT stated that the pandemic situation and the measures for containing it continued to influence the trend of road accidents and mobility in 2021. Compared to the previous year, accidents and injuries increased substantially in March-June 2021, returning to levels very close to those of the pre-pandemic period in the second half of the year. As per the same source, in the year 2021, around 204,728 were injured (+28.6%) and 151,875 is the number of road accidents number (+28.4%), all values increased in comparison to the previous year. Thus, the increasing number of road accidents is increasing the number of hospitalizations, which is expected to increase market growth over the forecast period. Similarly, product launches are another factor in market growth. For instance, in December 2021, CMR Surgical, a global surgical robotics business, introduced the Versius Surgical Robotic System at Policlinico di Milano, a leading research hospital and care institute (IRCCS) and one of the largest healthcare facilities in Lombardy, Italy. The minimally invasive surgeries using robotic surgery reduce the post-operative hospitalization time, which is a great advantage both for the patient and for the whole healthcare system. Thus, factors such as increasing road accidents and product launches are expected to increase segmental growth during the forecast period.

Italy General Surgical Devices Industry Overview

The market studied is moderately competitive, and there are several international as well as local companies that are present in Italy and are providing general surgery solutions. The major players in the Italy general surgical devices market are Abbott Laboratories, GE Healthcare, Koninklijke Philips NV, Medtronic PLC, Olympus Corporation, Siemens AG, Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet among others.

Italy General Surgical Devices Market Leaders

Italy General Surgical Devices Market News

• August 2022: LimaCorporate and Siemens partnered for CAD design and the preparation of 3D-printing jobs and TT lattice generation in Italy.
• March 2022: Bracco Imaging launched a new subsidiary, Blue Earth Therapeutics, to advance the development of next-generation therapeutic radiopharmaceutical technology in Italy.